GlassScriptPhysician profile
Ravikanth Chiravuri
NPI 1386845774
$15,079.81
in general payments reported to CMS, 2019-2025
41 companies · $933 in 2025
The $933 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,004 · 2020: $825 · 2021: $2,556 · 2022: $3,693 · 2023: $2,145 · 2024: $1,923 · 2025: $933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,001.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,000.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,336.08 | 2021-2025 | Micra, Mycarelink, Venaseal |
| Abbott Laboratories | $2,833.77 | 2019-2025 | Amplatzer Talisman, Amplatzer Amulet, Aveir |
| Shockwave Medical, INC | $1,462.30 | 2020-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $844.86 | 2022 | |
| Pfizer INC. | $477.54 | 2019-2025 | |
| Boston Scientific Corporation | $468.24 | 2021-2025 | General - Therapies |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $437.01 | 2019-2023 | Lifevest |
| Janssen Pharmaceuticals, INC | $353.02 | 2021-2024 | Xarelto |
| Cvrx, INC. | $306.04 | 2023-2024 | Barostim Neo System |
| Medtronic Vascular, INC. | $292.19 | 2019-2020 | |
| Penumbra, INC. | $283.55 | 2022-2024 | Penumbra System |
| Astrazeneca Pharmaceuticals LP | $259.45 | 2019-2025 | Wainua, Farxiga |
| Angiodynamics, INC. | $252.73 | 2022-2025 | Auryon Laser System 100-120 Vac |
| Heartflow, INC. | $250.52 | 2023-2025 | Ffrct |
| E.R. Squibb & Sons, L.L.C. | $226.44 | 2020-2025 | Camzyos |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $220.68 | 2019-2024 | Jardiance |
| Terumo Medical Corporation | $216.68 | 2021-2023 | Optitorque, Heartrail, Metacross Otw |
| Novartis Pharmaceuticals Corporation | $201.91 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $151.12 | 2022-2024 | Verquvo |
| Amarin Pharma, INC. | $142.55 | 2019-2021 | |
| Irhythm Technologies, INC. | $135.71 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Akcea Therapeutics, INC. | $134.40 | 2019 | |
| Amgen INC. | $124.80 | 2021 | |
| Bard Peripheral Vascular, INC. | $110.24 | 2020 | |
| Philips North America LLC | $84.41 | 2020 | |
| Kerecis Limited | $83.13 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Baxter Healthcare | $60.04 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Cardiva Medical, INC. | $48.56 | 2019 | |
| Abiomed | $37.11 | 2024 | Impella |
| Becton, Dickinson and Company | $35.56 | 2024 | Lutonix Drug Coated Balloon |
| Edwards Lifesciences Corporation | $29.67 | 2024 | |
| Kestra Medical Technology Services, INC. | $29.66 | 2024 | Assure Wcd |
| Ge Healthcare | $28.06 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $22.80 | 2022 | |
| Astellas Pharma US INC | $21.54 | 2021 | |
| Octapharma USA, INC. | $20.73 | 2023 | Octagam Immune Globulin (Human) |
| Kiniksa Pharmaceuticals, LTD. | $17.20 | 2023 | Arcalyst |
| Novo Nordisk INC | $13.53 | 2025 | Ozempic |
| Cmp Pharma, INC. | $13.48 | 2020 | |
| Bardy Diagnostics, INC. | $12.50 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravikanth Chiravuri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.